Verrucous carcinoma in epidermolysis bullosa simplex is possibly associated with a novel mutation in the keratin 5 gene.
Epidermolysis bullosa simplex (EBS) is mainly caused by mutations in the KRT5 and KRT14 genes. Squamous cell carcinoma (SCC) represents the second most frequent skin neoplasia with complex aetiology. The molecular events disrupting the orchestrated interplay between the cytoskeleton, cell adhesion molecules and signalling proteins are ill understood in SCC. We describe the molecular background and the unusual course of the disease in a patient with EBS Dowling-Meara, severe keratoderma and a massive verrucous carcinoma. Skin and tumour samples from the patient were analysed using light microscopy, immunohistochemistry and immunofluorescence mapping. Mutation analysis of the KRT5 and KRT14 genes identified the novel KRT5 mutation p.E477D. Invasive tumour areas were characterized by downregulation of keratins 5 and 14, reduced and irregular desmocollin-2 expression and increased expression of keratins 6, 16 and 17. Levels of Ki-67 were increased and levels of E-cadherin strongly reduced in the tumour tissue. In this case a novel KRT5 mutation led to increased fragility of keratinocytes. Desmosome and adherens junctions were destabilized, which may trigger keratinocyte-mediated inflammation, possibly via p120-catenin-dependent signalling, suggesting a link between a keratin mutation and SCC, which adds weight to the hypothesis that disturbance of the cytoskeleton represents a major cause in the appearance of the malignant phenotype. Some individuals with EBS may be at risk of developing secondary SCC.
Department of Dermatology, University Medical Center, Freiburg, Germany. hauke.schumann@uniklinik-freiburg.de
H
H
Schumann
W
W
Roth
C
C
Has
A
A
Volz
C
C
Erfurt-Berge
T M
TM
Magin
L
L
Bruckner-Tuderman
D000328:Adult; D015820:Cadherins / Q000378:metabolism; D018289:Carcinoma, Verrucous / Q000150:complications* / Q000175:diagnosis / Q000235:genetics; D004252:DNA Mutational Analysis; D015536:Down-Regulation; D016110:Epidermolysis Bullosa Simplex / Q000150:complications* / Q000175:diagnosis / Q000235:genetics; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D007150:Immunohistochemistry; D053547:Keratin-14 / Q000235:genetics; D053555:Keratin-5 / Q000235:genetics*; D015603:Keratinocytes / Q000378:metabolism; D007633:Keratins / Q000378:metabolism; D019394:Ki-67 Antigen / Q000378:metabolism; D009154:Mutation / Q000235:genetics*; D012878:Skin Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000235:genetics; D014057:Tomography, X-Ray Computed
D015820:Cadherins; D053547:Keratin-14; D053555:Keratin-5; D019394:Ki-67 Antigen; D007633:Keratins